HomeAI · summaries
Storia in 12 fonti
A Novel Pill For Cholesterol: FDA Approves Lipfendra
The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Merck wins first approval of a PCSK9 cholesterol pill
The speedy clearance of Lipfendra is an important milestone for Merck and the result of a controversial voucher program put in place by former commissioner Marty Makary.
- ·
healio.com
FDA approves Lipfendra, the first oral PCSK9 inhibitor, to lower LDL
Merck and the FDA announced the approval of enlicitide 20 mg as an add-on to diet and exercise to lower LDL in adults with hypercholesterolemia and those with heterozygous…
- ·
medpagetoday.com
FDA Approves First PCSK9 Inhibitor in Pill Form
With enlicitide, large LDL cholesterol reductions possible without a needle
- ·
nbcnews.com
FDA approves new kind of cholesterol pill
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way than a statin to lower cholesterol.
- ·
benzinga.com
FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio - Merck & Co (NYSE:MRK)
Merck's Lipfendra wins FDA approval as the first oral PCSK9 inhibitor for adults with high LDL cholesterol after positive Phase 3 results.
- ·
economictimes.indiatimes.com
Merck gets US FDA nod for first-in-its-class oral cholesterol drug
The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which helps lower bad cholesterol. Lipfendra…
- ·
fortune.com
The cholesterol shot you couldn’t afford is now a pill | Fortune
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.
- ·
upi.com
FDA approves first pill to significantly lower 'bad' cholesterol - UPI.com
The Food and Drug Administration on Thursday approved Merck's Lipfendra, which some have hailed as a breakthrough in cholesterol management.
- ·
abcnews.com
FDA approves 1st-of-its-kind pill to reduce cholesterol
The Food and Drug Administration (FDA) approved on Thursday a first-of-its-kind oral option that can lower "bad" LDL cholesterol with a daily pill instead of a shot.
- ·
forbes.com
A Novel Pill For Cholesterol: FDA Approves Lipfendra
The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026.
- ·
ynetnews.com
FDA approves first cholesterol pill to match powerful injectable drugs
Merck’s once-daily Lipfendra offers a pill alternative to injectable cholesterol drugs after Phase 3 trials involving Israeli patients
- ·
hindustantimes.com
What do we know about the new cholesterol pill, Lipfendra? Merck's new once-a-day drug gets FDA nod
The FDA has approved Merck's once-daily cholesterol pill Lipfendra (enlicitide), marking the first oral PCSK9 inhibitor.